↓ Skip to main content

Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis

Overview of attention for article published in Systematic Reviews, November 2018
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (54th percentile)

Mentioned by

patent
1 patent

Readers on

mendeley
112 Mendeley